Forsøg SCAB2003 var en randomiseret, dobbeltblindet, placebo - og lithiumkontrolleret multicentervurdering med double dummy og faste doser af langtidsforebyggelsen af recidiv og tilbagefald af depression og/ eller mani hos patienter med bipolar affektiv sindslidelse af type I, der for nylig havde haft eller aktuelt havde en svær depressiv episode.
Study SCAB2003 was a multicentre, double-blind, double dummy, placebo and lithium-controlled, randomised fixed dose evaluation of the long-term prevention of relapse and recurrence of depression and/ or mania in patients with bipolar I disorder who had recently or were currently experiencing a major depressive episode.